PD-1 blockade in Japanese patients with acral lentiginous melanoma
Ann Oncol
.
2020 Sep;31(9):1106-1108.
doi: 10.1016/j.annonc.2020.06.014.
Epub 2020 Jul 3.
Author
A N Shoushtari
1
Affiliation
1
Department of Medicine, Melanoma and Immunotherapeutics Service, Memorial Sloan Kettering Cancer Center, New York, USA. Electronic address:
[email protected]
.
PMID:
32622883
DOI:
10.1016/j.annonc.2020.06.014
No abstract available
Publication types
Editorial
Comment
MeSH terms
Humans
Japan
Melanoma* / drug therapy
Programmed Cell Death 1 Receptor
Skin Neoplasms* / drug therapy
Substances
Programmed Cell Death 1 Receptor